MedPath

Stress Index to Individualize Mechanical Ventilation in ARDS

Not Applicable
Terminated
Conditions
Acute Respiratory Distress Syndrome
Registration Number
NCT02871102
Lead Sponsor
Vanderbilt University
Brief Summary

Acute respiratory distress syndrome (ARDS) is a widely prevalent and morbid disease for which the current standard treatment is supportive care and avoidance of complications with lung-protective ventilation. Lower-tidal volume ventilation has been largely accepted as a means of lung protective ventilation, but the mechanism for its effectiveness is not yet clear, and debate remains as to how best to choose positive end-expiratory pressure (PEEP). Reduction in driving pressure (plateau pressure minus PEEP) has been suggested as a possible means to minimize ventilator-induced lung injury. This protocol aims to identify the range of safe paired-settings of PEEP and tidal volume, with selection guided by driving pressure and the stress index, a tool to recognize potential lung hyperinflation during mechanical ventilation.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
4
Inclusion Criteria
  • Admitted to the Intensive Care Unit
  • Receiving invasive mechanical ventilation via endotracheal or tracheostomy tube
  • Presence of ARDS by Berlin Criteria (acute onset bilateral pulmonary infiltrates incompletely explained by left heart failure together with a PaO2/FiO2 of <300 or SpO2/FiO2 <315)
Exclusion Criteria
  • Inability to obtain surrogate consent

  • Presence of specified comorbidities:

    1. pregnancy
    2. pre-existing severe chronic obstructive pulmonary disease, defined as FEV1 documented < 1L or baseline hypercapnia
    3. cerebral edema
    4. known intra-cranial abnormality
    5. acute coronary syndrome
  • Endotracheal or tracheostomy cuff leak

  • Chest tube with persistent air leak

  • Severe hemodynamic instability (defined as attending judgment that the patient is unable to safely tolerate ventilator manipulations)

  • Presence of spontaneous respiratory activity as evidenced by examination of the ventilator waveform tracing

  • Intrinsic PEEP of > 5 cmH2O

  • Assessment of study staff or patient's attending physician that the patient would not be a good study participant

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Comparison of ARDSnet-optimized and protocol-optimized tidal volumeCompletion of the study intervention, less than 1 day

Mean absolute difference between tidal volume in cc/kg PBW prescribed by ARDSnet settings on ARDSnet PEEP versus maximal protective tidal volume defined by stress index \<1.05 at the ARDSnet PEEP on experimental protocol.

Comparison of ARDSnet-optimized and protocol-optimized driving pressureCompletion of the study intervention, less than 1 day

Mean difference in driving pressure prescribed by ARDSnet settings versus at lowest measured possible driving pressure that achieves equivalent minute ventilation as ARDSnet table with respiratory rate \< or = 35 per minute and SI \<1.05.

Secondary Outcome Measures
NameTimeMethod
Comparison of ARDSnet-optimized and protocol-optimized PEEPCompletion of the study intervention, less than 1 day

Mean absolute difference between safest PEEP as determined by experimental protocol with tidal volume of 6 mL/kg PBW (defined as the PEEP at which 6 mL/kg PBW yields the lowest driving pressure with a SI \<1.05) versus the PEEP established by ARDSnet table.

Comparison of ARDSnet-optimized and protocol-optimized elastanceCompletion of the study intervention, less than 1 day

Mean difference in elastance prescribed by ARDSnet settings versus at lowest measured possible elastance achieving equivalent minute ventilation as ARDSnet table with respiratory rate \< or = 35 per minute.

Trial Locations

Locations (1)

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

Vanderbilt University Medical Center
🇺🇸Nashville, Tennessee, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.